mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
基本信息
- 批准号:8894191
- 负责人:
- 金额:$ 47.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnti-Bacterial AgentsAntibodiesAntiviral AgentsBacteriaBacterial InfectionsBiologicalCD4 Positive T LymphocytesCD8B1 geneCancer VaccinesCellsCharacteristicsClinicalCodeComplexCross PresentationCross-PrimingDataDendritic CellsDiseaseEnterovirusEpitopesFamilyFlavivirusGoalsGrantImmuneImmune responseImmunityIn VitroInfectionInjection of therapeutic agentLinkMHC Class I GenesMediator of activation proteinMessenger RNAMolecularMusNamesOrganismPathway interactionsPeptidesPlayPoxviridaeProcessPropertyProteinsRNARecombinantsRegulatory ElementRouteSurfaceT cell responseT-LymphocyteTestingTransfer RNATranslatingTranslationsUncertaintyVaccinesViralViral ProteinsVirusVirus DiseasesWorkextracellularimmunogenicin vivomicrobialpathogenpublic health relevancetumor
项目摘要
DESCRIPTION (provided by applicant): In vivo injection of mRNA triggers immune responses to the encoded proteins, and confers protection against disease. For this and other reasons, outlined below, RNA vaccines have great clinical potential, so it is important that we understand how they induce immunity. I hypothesize that RNA vaccines may be exploiting a biological pathway that has evolved specifically to capture, internalize, and translate mRNA. I propose that this pathway facilitates the transfer of immunological information into uninfected dendritic cells (DCs), thereby playing a key part in regulating CD8+ T cell responses to many viral and bacterial infections. Almost all acute virus infections induce strong CD8+ T cell responses, which are initiated when na�ve CD8+ T cells are activated by contact with an MHC class I / epitope peptide complex on the surface of DCs that express appropriate costimulatory molecules. However, many viruses do not infect DCs; and some viruses that infect DCs also encode proteins that quite effectively inhibit MHC class I presentation. These facts posed a puzzle: how could epitopes encoded by these viruses be effectively presented by DCs? The answer came with the identification of cross-presentation which, if it results in the triggering of
naive CD8+ T cells, causes cross-priming. However, two in vivo observations show that cross-presentation/cross-priming (hereinafter, CP) is not always highly-efficient. First, enteroviruses replicate to very high titers and induce CD4+ T cells and antibodies, yet (unique among acute virus infections) they completely avoid triggering na�ve CD8+ T cells. Second, extracellular bacterial infections, in which microbial protein is hugely abundant, do not induce strong CD8+ T cell responses. For reasons described below, I hypothesize that both observations can be explained by proposing that some transfer of immunological information into uninfected DCs may rely on mRNA (rather than protein). So, this proposal has two goals: First, to evaluate how naked RNA induces immunity. Second, to test the hypothesis that, during most microbial infections, mRNA is transferred to uninfected DCs; if it is translated therein, the encoded protein
will reach the class I MHC pathway, inducing strong CD8+ T cell responses; I have named this mechanism TATOR (transfer and translation of RNA). Conversely, if the mRNA cannot be translated, the organism is undetectable by CD8+ T cells. Thus, the specific characteristics of their mRNAs renders enteroviruses and extracellular bacteria invisible to CD8+ T cells. Aim 1. To identify and characterize the DC subset that is involved in RNA-triggered immunity. Aim 2. To ask if mRNA coding strategy explains how enteroviruses can almost completely evade naive CD8+ T cells, while most viruses induce strong CD8+ T cell responses. Aim 3. To determine if mRNA regulatory sequences explain why extracellular bacteria fail to induce strong CD8+ T cell responses.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J. Lindsay Whitton其他文献
J. Lindsay Whitton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J. Lindsay Whitton', 18)}}的其他基金
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
- 批准号:
9225171 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
- 批准号:
8795589 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Coxsackieviral pancreatitis: autophagy, proteolysis, and inflammation
柯萨奇病毒性胰腺炎:自噬、蛋白水解和炎症
- 批准号:
9027796 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
- 批准号:
9198190 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Analyzing the effects of type I interferons in the enterovirus-infected heart
分析 I 型干扰素对肠道病毒感染心脏的影响
- 批准号:
8997975 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
- 批准号:
8735569 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
- 批准号:
8811097 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
How do enteroviruses almost completely evade the attentions of CD8+ T cells?
肠道病毒是如何几乎完全逃避CD8 T细胞的注意的?
- 批准号:
8630094 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
mRNA as a mediator of immunological information transfer in vivo
mRNA 作为体内免疫信息传递的介质
- 批准号:
8854024 - 财政年份:2014
- 资助金额:
$ 47.38万 - 项目类别:
Cytotoxic T Cell Responses to Virus Infection
细胞毒性 T 细胞对病毒感染的反应
- 批准号:
8524204 - 财政年份:2012
- 资助金额:
$ 47.38万 - 项目类别:
相似国自然基金
基于呫吨酮的拟肽抗菌剂设计合成、抗菌活性和分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
土壤真菌群落对典型三唑类抗菌剂的抗药性响应特征和机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
二(苯乙烯基)酮类光敏抗菌剂的设计,合成及应用研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
- 批准号:
10726417 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
FimH-Targeting Antibody-Recruiting Molecules as Novel Drugs for Preventing Complicated Urinary Tract Infections
FimH 靶向抗体招募分子作为预防复杂性尿路感染的新药
- 批准号:
10603693 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts
异常肽聚糖片段的自然释放导致易感宿主持续出现莱姆病症状
- 批准号:
10736544 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infection
评估巨噬细胞抗病毒免疫作为 SIV-M 的抑制因素。
- 批准号:
10547182 - 财政年份:2022
- 资助金额:
$ 47.38万 - 项目类别:
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infection
评估巨噬细胞抗病毒免疫作为 SIV-M 的抑制因素。
- 批准号:
10628021 - 财政年份:2022
- 资助金额:
$ 47.38万 - 项目类别: